ArticleScientific reports2021

Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence population.

Gheyath K Nasrallah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.